| Financial Year |
March 31 2023 |
| Monetary Funds |
282,224,238.49 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
46,693,306.75 |
| Advances to Suppliers |
78,303,068.26 |
| Other Receivables |
193,991,684.86 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
5,986,941,302.78 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
126,462,638.81 |
| Total Current Assets |
6,714,616,239.95 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
109,580,235.50 |
| Investment Properties |
422,920,140.00 |
| Fixed Assetes |
3,642,067,368.57 |
| Under-construction Projects |
11,986,466.88 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
326,676,215.90 |
| R&D expenses |
-- |
| Goodwill |
58,361,347.57 |
| Long-Term Deferred and Prepaid Expenses |
30,449,546.77 |
| Deferred Income Tax Assets |
150,222,127.09 |
| Other Non-Current Assets |
25,954,449.86 |
| Sub-Total of Non-Current Assets |
5,495,780,517.51 |
| Total Assets |
12,210,396,757.46 |
| Short-Term Loans |
4,785,847,550.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
3,000,000.00 |
| Accounts Payable |
1,768,712,582.07 |
| Accounts Received In Advance |
55,112,533.37 |
| Employee Compensation Payable |
22,997,920.01 |
| Taxes Payable |
441,610,655.10 |
| Interest Payable |
127,017,781.92 |
| Dividend Payable |
125,025,861.28 |
| Other payables |
780,288,570.19 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
577,723,683.10 |
| Other Current Liabilities |
86,899,119.11 |
| Sub-Total of Current Liabilities |
9,710,356,006.89 |
| Long-term Loans |
430,259,967.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
29,876,276.58 |
| Deferred Income Tax Liabilities |
59,145,657.23 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,578,733,495.56 |
| Total Liabilities |
11,289,089,502.45 |
| Paid-In Capital(Or Share Stock) |
1,128,334,788.00 |
| Capital Surplus |
3,247,402.64 |
| Surplus Reserve |
311,932,359.10 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-703,741,392.15 |
| Minority Stockholder's Interest |
29,065,891.76 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
892,241,363.25 |
| Owner's Equity（Stockholder's Equity） |
921,307,255.01 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
12,210,396,757.46 |
